Geode Capital Management
PLYX icon

Geode Capital Management’s Polaryx Therapeutics Inc PLYX Stock Holding History

Geode Capital Management’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$287K Sell
138,757
-32,241
-19% -$70.2K ﹤0.01% 3751
2026
Q2 		$455K Buy
170,998
+325
+0.2% +$1.28K ﹤0.01% 3643
2026
Q1 		$1.29M Buy
+170,673
New +$1.1M ﹤0.01% 3283

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Geode Capital Management's PLYX Position: Q3 2026 in Review

Geode Capital Management reduced its Polaryx Therapeutics Inc (PLYX) stake by 19% in Q3 2026, selling an estimated $70.2K and leaving 138,757 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

Geode Capital Management first reported a position in PLYX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.29M in Q1 2026. 11 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

  • Geode Capital Management held 138,757 shares of Polaryx Therapeutics Inc worth $287K as of Q3 2026.
  • Geode Capital Management sold 32,241 Polaryx Therapeutics Inc shares in Q3 2026, an estimated $70.2K.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3751 holding.
  • Geode Capital Management first reported a position in Polaryx Therapeutics Inc in Q1 2026 and has held it in 3 quarters since.
  • Geode Capital Management's Polaryx Therapeutics Inc position peaked at $1.29M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.